The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
5 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $2,073,097 in first-year total cost, median $404,181.
Most frequent study sections
- Special Emphasis Panel[ZHD1 DSR-Z (55)]5
Most frequent institutions
- LUNDQUIST INSTITUTE FOR BIOMEDICAL INNOVATION AT HARBOR-UCLA MEDICAL CENTER1
- OREGON HEALTH & SCIENCE UNIVERSITY1
- UNIVERSITY OF MINNESOTA1
- UNIVERSITY OF TEXAS SAN ANTONIO1
- YALE UNIVERSITY1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2024 | Inhibiting the cystic fibrosis transmembrane conductance regulator (CFTR) in the cervix as a novel approach to non-hormonal contraception1R61HD114161-01 | HAN, LEO LIU | OREGON HEALTH & SCIENCE UNIVERSITY, OR | $438,089 | ZHD1 |
| 2024 | Engineering and targeting the sperm-specific calcium channel CatSper for contraception1R61HD114344-01 | CHUNG, JEAN-JU LUCIA | YALE UNIVERSITY, CT | $425,827 | ZHD1 |
| 2024 | Development of small molecule inhibitors of RBM46 as novel male contraceptives1R61HD114223-01 | GEYER, CHRISTOPHER BENNETTHERMANN, BRIAN PETERYUAN, YAXIA | UNIVERSITY OF TEXAS SAN ANTONIO, TX | $404,181 | ZHD1 |
| 2024 | IND-enabling studies to develop triptonide into the first nonhormonal male pill1R61HD114186-01 | NICKELS, LOGANYAN, WEI | LUNDQUIST INSTITUTE FOR BIOMEDICAL INNOVATION AT HARBOR-UCLA MEDICAL CENTER, CA | $403,750 | ZHD1 |
| 2024 | Catsper Inhibitors for Male Contraception1R61HD114221-01 | GEORG, GUNDA I. | UNIVERSITY OF MINNESOTA, MN | $401,250 | ZHD1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.